Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer
NCT02432365Phase 2Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Feb 2015
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, cisplatin in Cervical Cancer (CC), sponsored by Chang Gung Memorial Hospital. Status: unknown.
02
Drugs
paclitaxelcisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02432365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02432365.